Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 630 | 33 | 0.4763 | 0.6184 | 0.0524 | 0.0487 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 855 | 222 | 0.5051 | 0.5481 | 0.2596 | 0.2669 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 1046 | 285 | 0.6072 | 0.5481 | 0.2725 | 0.2669 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 912 | 245 | 0.5322 | 0.5481 | 0.2686 | 0.2669 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 774 | 111 | 0.5290 | 0.5769 | 0.1434 | 0.1727 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 941 | 195 | 0.5952 | 0.5769 | 0.2072 | 0.1727 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 913 | 153 | 0.6064 | 0.5769 | 0.1676 | 0.1727 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 977 | 144 | 0.6646 | 0.5335 | 0.1474 | 0.1422 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 820 | 119 | 0.5593 | 0.5335 | 0.1451 | 0.1422 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 545 | 73 | 0.3766 | 0.5335 | 0.1339 | 0.1422 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 823 | 140 | 0.5449 | 0.4894 | 0.1701 | 0.1367 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 788 | 98 | 0.5505 | 0.4894 | 0.1244 | 0.1367 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 528 | 61 | 0.3726 | 0.4894 | 0.1155 | 0.1367 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 644 | 234 | 0.3271 | 0.3431 | 0.3634 | 0.3687 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 642 | 245 | 0.3168 | 0.3431 | 0.3816 | 0.3687 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 756 | 273 | 0.3854 | 0.3431 | 0.3611 | 0.3687 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 486 | 158 | 0.2617 | 0.2955 | 0.3251 | 0.3065 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 601 | 178 | 0.3375 | 0.2955 | 0.2962 | 0.3065 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 513 | 153 | 0.2872 | 0.2955 | 0.2982 | 0.3065 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 819 | 228 | 0.4715 | 0.3311 | 0.2784 | 0.2885 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 2 | 587 | 183 | 0.3223 | 0.3311 | 0.3118 | 0.2885 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 345 | 95 | 0.1995 | 0.3311 | 0.2754 | 0.2885 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 545 | 138 | 0.3247 | 0.2628 | 0.2532 | 0.2739 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 434 | 114 | 0.2553 | 0.2628 | 0.2627 | 0.2739 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 376 | 115 | 0.2082 | 0.2628 | 0.3059 | 0.2739 |